Demographic and clinical characteristics of 96 patients randomized to treatment of Azithromycin (n = 50) or placebo (n = 46) and by ethnicity.

<p><b>Median and IQR (25–75) for continuous variables. Actual numbers for categorical variables and percentages.</b></p><p><b>NB</b>: Missing variables described.</p><p><b>Azithromycin</b>: Gestational age  = 3 (6%). Birth weight  = 6 (12%). Mother smoked during pregnancy  = 3 (6%). Exposure to household smoke  = 2 (4%), <b>Placebo</b>: Gestational age:  = 2 (4%). Birth weight  = 3 (6.5%).</p><p><b>Indigenous children</b>: Gestational age  = 2 (3.3%). Birth weight  = 4 (6.5%). Mother smoked during pregnancy  = 2 (3%). Exposure to household smoke  = 1 (1.6%): <b>Non Indigenous children</b>: Gestational age:  = 3 (8.6%). Birth weight  = 5 (14.3%) Mother smoked during pregnancy  = 1 (3%). Exposure to household smoke  = 1 (3%).</p

Time to first readmission – Indigenous Vs Non-Indigenous.

<p>Time to first readmission – Indigenous Vs Non-Indigenous.</p

Bacteria outcomes at pre treatment (baseline) and post treatment (48 hours).

<p>Bacteria outcomes at pre treatment (baseline) and post treatment (48 hours).</p

Length of stay (LOS) in hospital – Azithromycin Vs Placebo and Ethnicity.

<p>Length of stay (LOS) in hospital – Azithromycin Vs Placebo and Ethnicity.</p

Time to first readmission – Azithromycin Vs Placebo.

<p>Time to first readmission – Azithromycin Vs Placebo.</p

CONSORT trial overview.

<p>CONSORT trial overview.</p

Subgroup analysis of LOS and time on O₂ by ethnicity and age.

<p>Subgroup analysis of LOS and time on O₂ by ethnicity and age.</p

Frequency of viruses detected in NPS – Baseline and 48 hours.

<p>Frequency of viruses detected in NPS – Baseline and 48 hours.</p

Time on Oxygen (O₂) in hospital – Azithromycin Vs Placebo and Ethnicity.

<p>Time on Oxygen (O₂) in hospital – Azithromycin Vs Placebo and Ethnicity.</p